Tonghua Dongbao Pharmaceutical – World Class Benchmarking
Company: Tonghua Dongbao Pharmaceutical Company Limited
Bloomberg ticker: 600867 SH
Market cap: US$2,553m
Background: Tonghua Dongbao Pharmaceutical Company Limited manufactures Western medicines, Chinese medicines, biological products, and plastic building materials.
World Class Benchmarking of Tonghua Dongbao Pharmaceutical
- Profitable Growth rank of 1 was up compared to the prior period’s 2nd rank
- This is World Class performance compared to 440 medium Health Care companies worldwide
- Profitability rank of 1 was better than its Growth rank of 3
- Profitability rank of 1 was the same compared to the prior period’s 1st rank
- This is World Class performance compared to peers
- Growth rank of 3 was up compared to the prior period’s 6th rank
- This is above average performance compared to peers
DISCLAIMER: This content is for information purposes only. It is not intended to be investment advice. Readers should not consider statements made by the author(s) as formal recommendations and should consult their financial advisor before making any investment decisions. While the information provided is believed to be accurate, it may include errors or inaccuracies. The author(s) cannot be held liable for any actions taken as a result of reading this article.